(17, 18) Previous screening of human leukocyte antigens (HLA) class II DR genes found that HLA-DRB1*15 (Odds ratio value = 15.89) and DRB5 alleles were more likely to be represented in MS patients. Here, HLA-DRB1 is linked to myeloid sarcoma.